Subject(s)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/ethnology , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/genetics , Genetic Predisposition to Disease , Polymorphism, Genetic , Protein Tyrosine Phosphatase, Non-Receptor Type 22/genetics , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/metabolism , Gene Frequency , Humans , Mexico/epidemiology , Polymerase Chain Reaction , Protein Tyrosine Phosphatase, Non-Receptor Type 22/metabolism , Risk Management